antibiotic K 4: from Actinomadura spiculosospora [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5487705 |
| MeSH ID | M0139865 |
| Synonym |
|---|
| l-phenylalaninamide, n-methyl-l-valyl-n-(2-(4-hydroxyphenyl)-1-phosphonoethyl)-, (r)- |
| i5b1 |
| i5-b1 |
| k 4 |
| 84890-90-4 |
| antibiotic k 4 |
| [(1r)-2-(4-hydroxyphenyl)-1-[[(2s)-1-[[(2s)-3-methyl-2-(methylamino)butanoyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]ethyl]phosphonic acid |
| k-4 |
| [(1r)-2-(4-hydroxyphenyl)-1-[[(1s)-1-[[(2s)-3-methyl-2-methylamino-butanoyl]carbamoyl]-2-phenyl-ethyl]amino]ethyl]phosphonic acid |
| DTXSID90233941 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||